• Login
    View Item 
    •   UBIR Home
    • Theses and Dissertations (2018-present)
    • 2019-02-01 UB Theses and Dissertations (public)
    • View Item
    •   UBIR Home
    • Theses and Dissertations (2018-present)
    • 2019-02-01 UB Theses and Dissertations (public)
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    A Lipidomics-Based Approach to Study Fatostatin-Induced Toxicity

    Thumbnail
    View/Open
    Morrow_buffalo_0656M_16186.pdf (1.792Mb)
    Date
    2019
    Author
    Morrow, Lauren
    Metadata
    Show full item record
    Abstract
    Despite the well-known biological heterogeneity that exists between different types of cancer, they each undergo metabolic reprogramming to promote unregulated proliferation and tumor growth. This metabolic reprogramming involves the upregulation of processes that help the cell to meet increased bioenergetic and biosynthetic needs. One such process is fatty acid biosynthesis, which provides cells with thousands of diverse lipid species, each with unique functional roles for membrane structures or cellular signaling. The development of a targeted drug therapy to inhibit fatty acid biosynthesis could therefore have an impact on the treatment of many types of cancer. The small molecule fatostatin, which downregulates fatty acid biosynthesis through inhibition of a key transcription factor, has thus become the subject of many research investigations due to its potential as a widely effective cancer therapeutic agent. Through these studies, anti-tumor, anti-lipogenic, and anti-mitotic properties of fatostatin have been established. Despite wide interest and extensive research efforts, the mechanisms of fatostatin’s anti-cancer effects remain unclear. To investigate these effects, we used cell viability assays to examine the anti-proliferative effect of fatostatin on cancerous and non-cancerous cell lines, revealing different responses to treatment over time. To better understand the mechanisms responsible for these anti-cancer effects, we employed a global lipidomic analysis to investigate the lipidome during fatostatin treatment. This approach offers unbiased identification of lipid species that significantly change in abundance during fatostatin treatment, indicating that they are likely linked to fatostatin’s mechanism. Untargeted analysis has revealed the accumulation of unsaturated triacyglycerols and fatty acids and the depletion of acyl carnitines during fatostatin treatment. We have begun to investigate the mechanisms responsible for these regulation changes, providing new insight into fatostatin’s mode of action.
    URI
    http://hdl.handle.net/10477/79314
    Collections
    • 2019-02-01 UB Theses and Dissertations (public)

    To add content to the repository or for technical support: Contact Us
     

     

    Browse

    All of UBIRCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    To add content to the repository or for technical support: Contact Us